|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/57 | |
| A61P 15/16 |
| (11) | Number of the document | 1666044 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06075322.5 |
| Date of filing the European patent application | 2001-02-15 | |
| (97) | Date of publication of the European application | 2006-06-07 |
| (45) | Date of publication and mention of the grant of the patent | 2010-07-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 00200493 | 2000-02-15 | EP | |
| 503729 | 2000-02-15 | US |
| (72) |
Habenicht, Ursula-Friederike, DE
Kamischke, Axel, DE
Nieschlag, Eberhard, DE
Oettel, Michael, DE
Rübig, Alexander, CL
Schillinger, Ekkerhard, DE
|
| (73) |
Bayer Schering Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (54) | Male contraceptive formulation comprising norethisterone |
| Male contraceptive formulation comprising norethisterone |